Global News
-
26-03-2010Sandoz statement on passage of US biosimilars pathway legislation
We welcome the passage of a US biosimilars pathway, which means that patients and payors in the US are now set to gain access to safe and effective biosimilars, such as those pioneered by Sandoz in Europe and elsewhere.
-
26-01-2010Latest Results - Full Year/Q4 2009
Novartis achieves record results in 2009 as momentum from recently launched products drives growth across its entire healthcare portfolio
-
22-10-2009Latest results
Novartis delivers strong new product momentum and operational performance in first nine months of 2009
-
05-10-2009Sandoz launches first-ever Japanese biosimilar
broadening access to medicines in second largest global market
-
24-09-2009Sandoz completes acquisition of EBEWE Pharma
Improving global patient access to affordable injectable cancer medicines
-
10-09-2009Sandoz Receives 2009 Best of Princeton Award
U.S. Commerce Association’s Award Plaque Honors the Achievement
-
11-08-2009Important product launch in the US
Sandoz launches first generic version of Prograf® capsules
-
29-07-2009Major investment
Sandoz opens extension to Aeropharm production facility in Rudolstadt / Thuringia
-
21-07-2009New economic study
Sandoz as “jewel in German industrial crown”
-
16-07-2009Latest results - second quarter and first half 2009
Novartis delivers strong operational performance in the first half of 2009 driven by sustained Pharmaceuticals innovation
